Skip to main content
Premium Trial:

Request an Annual Quote

Eurofins-Medigenomix-MWG Biotech Buy 454 GS20 for Service Business

NEW YORK (GenomeWeb News) — Eurofins-Medigenomix-MWG Biotech has acquired a 454 Life Sciences Genome Sequencer 20 instrument from Roche and expects to install it next week in Medigenomix’s German research facility, the companies said last week. 
 
By combining the GS20 with the companies’ current sequencing platform, which is “mainly based” on the Sanger method, MWG and Medigenomix will be able to sequence and compare bacterial genomes in “a couple of days.”
 
MWG Biotech, based in Ebersberg, Germany, performs DNA sequencing services, and in August 2005 it joined forces with Eurofins Medigenomix, which performs DNA-analysis services for biopharma companies and academic institutions.
 
The deal makes Eurofins-Medigenomix-MWG Biotech the first sequencing provider in Germany using GS20 in-house. The placement comes a few weeks after another German company, Konstanz-based GATC Biotech, said it reached a licensing agreement to use the GS20 for sequencing and for mutation analysis. It was not immediately clear if GATC has placed a GS20 in-house.
 
Financial terms of the Eurofins-Medigenomix-MWG Biotech deal were not released.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.